July 1, 2021

Pepex Biomedical Receives Approval on a Series of Critical New Patents

Worldwide approval grants the Company exclusivity on a number of methods and manufacturing processes associated with its novel electrochemical biosensors. 

Feb 11, 2021

Phase One Development of Rapid COVID-19 Point of Care Test Complete

Pepex Biomedical has effectively concluded first stage development efforts including successfully demonstrating working chemistry and manufacturing functionality of its existing electrochemical biosensor. 

Nov 9, 2020

PEPEX ANNOUNCES NEW RAPID COVID-19 POINT OF CARE TEST

Pepex Biomedical has diverted funds and resources to the development of Multiple Rapid Covid-19 Tests designed to accurately identify Antigens (diagnostic to detect active virus) and Antibodies (to determine immunity) in under 15 minutes with 95% accuracy